Procedure
PET Scanning
PET Scanning is a medical procedure with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph early_phase_1
1
33%
Ph not_applicable
2
67%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
completed267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completedearly_phase_1
Evaluation of 18 F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
NCT02236754
completednot_applicable
PET Imaging in ALS Patients
NCT02236897
unknownnot_applicable
Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
NCT00330109
Clinical Trials (3)
Showing 3 of 3 trials
NCT02236754Early Phase 1
Evaluation of 18 F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
NCT02236897Not Applicable
PET Imaging in ALS Patients
NCT00330109Not Applicable
Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3